Effects of Exenatide-4 on proliferation, migration and osteogenic differentiation of human periodontal ligament stem cells

doi:10.19439/j.sjos.2020.03.001

Abstract

Abstract: PURPOSE: To investigate the effects of exendin-4(EX-4) on proliferation, migration and osteogenic differentiation of human periodontal ligament stem cells(PDLSCs). METHODS: PDLSCs were isolated and cultured using limited dilution method in vitro. Colony formation assay, osteogenic and adipogenic differentiation were applied to identify the stem cells. Immunofluorescence staining was used to detect the expression of EX-4 receptor glucagon-like peptide-1 receptor (GLP-1R) on the surface of PDLSCs. PDLSCs were stimulated with 5, 10, 20 or 50 nmol/L EX-4 in vitro. CCK-8, Transwell assay and alkaline phosphatase(ALP) activity assay were used to determine the effects of EX-4 on PDLSCs proliferation, migration and osteogenic differentiation. Quantitative real-time polymerase chain reaction was used to determine the expression of osteogenic related genes ALP, runt-related transcription factor 2(Runx2) and osteocalcin (OCN). The data were analyzed by Graphpad Prims 6.0 software package. RESULTS: PDLSCs were successfully isolated and cultivated. GLP-1R positively expressed on the surface of PDLSCs. EX-4 exerted no significant effect on PDLSCs proliferation(P>0.05). EX-4 significantly promoted migration, ALP activity and osteogenic related genes expression of PDLSCs (P<0.05). CONCLUSIONS: 10 nmol/L EX-4 could promote migration and osteogenic differentiation of PDLSCs.

Key words: Periodontal ligament stem cells, Exendin-4, Osteogenic differentiation

CLC Number:

R781.4

LIANG Qian-yu, DU Ling-qian, ZHANG Rui, DING Tian, GE Shao-hua. Effects of Exenatide-4 on proliferation, migration and osteogenic differentiation of human periodontal ligament stem cells[J]. Shanghai Journal of Stomatology, 2020, 29(3): 225-230.

References

[1] Papapanou PN, Susin C.Periodontitis epidemiology: is periodontitis under-recognized, over-diagnosed, or both?[J]. Periodontol 2000, 2017, 75(1): 45-51.
[2] Slots J.Periodontitis: facts, fallacies and the future[J]. Periodontol 2000, 2017, 75(1): 7-23.
[3] Cardoso EM, Reis C, Manzanares-Céspedes MC.Chronic periodontitis, inflammatory cytokines, and interrelationship with other chronic diseases[J]. Postgrad Med, 2018, 130(1): 98-104.
[4] Bartold PM, Gronthos S, Ivanovski S, et al.Tissue engineered periodontal products[J]. J Periodontal Res, 2016, 51(1): 1-15.
[5] Chen FM, Jin Y.Periodontal tissue engineering and regeneration: current approaches and expanding opportunities[J]. Tissue Eng Part B Rev, 2010, 16(2): 219-255.
[6] Park CH, Kim KH, Lee YM, et al.Advanced engineering strategies for periodontal complex regeneration[J]. Materials (Basel), 2016, 9(1): E57.
[7] Seo BM, Miura M, Gronthos S, et al.Investigation of multipotent postnatal stem cells from human periodontal ligament[J]. Lancet, 2004, 364(9429): 149-155.
[8] Ding G, Liu Y, Wang W, et al.Allogeneic periodontal ligament stem cell therapy for periodontitis in swine[J]. Stem Cells, 2010, 28(10): 1829-1838.
[9] Akizuki T, Oda S, Komaki M, et al.Application of periodontal ligament cell sheet for periodontal regeneration: a pilot study in beagle dogs[J]. J Periodontal Res, 2005, 40(3): 245-251.
[10] Du L, Feng R, Ge S.PTH/SDF-1α cotherapy promotes proliferation, migration and osteogenic differentiation of human periodontal ligament stem cells[J]. Cell Prolif, 2016, 49(5): 599-608.
[11] Yap MKK, Misuan N.Exendin-4 from Heloderma suspectum venom: From discovery to its latest application as type II diabetes combatant[J]. Basic Clin Pharmacol Toxicol, 2019, 124(5): 513-517.
[12] Sharma D, Verma S, Vaidya S, et al.Recent updates on GLP-1 agonists: current advancements & challenges[J]. Biomed Pharmacother, 2018, 108: 952-962.
[13] Zhang Y, Chen S, Liu B, et al.Exendin-4 promotes proliferation of adipose-derived stem cells through ERK and JNK signaling pathways[J]. In Vitro Cell Dev Bio Anim, 2016, 52(5): 598-606.
[14] Zhou H, Li D, Shi C, et al.Effects of Exendin-4 on bone marrow mesenchymal stem cell proliferation, migration and apoptosis in vitro [J]. Sci Rep, 2015, 5: 12898.
[15] Seo E, Lim JS, Jun JB, et al.Exendin-4 in combination with adipose-derived stem cells promotes angiogenesis and improves diabetic wound healing[J]. J Trans Med, 2017, 15(1): 35.
[16] Meng J, Ma X, Wang N, et al.Activation of GLP-1 receptor promotes bone marrow stromal cell osteogenic differentiation through β-Catenin[J]. Stem Cell Reports, 2016, 6(4): 579-591.
[17] Feng Y, Su L, Zhong X, et al.Exendin-4 promotes proliferation and differentiation of MC3T3-E1 osteoblasts by MAPK activation[J]. J Mol Endocrinol, 2016, 56(3): 189-199.
[18] Luciani P, Fibbi B, Mazzanti B, et al.The effects of Exendin-4 on bone marrow-derived mesenchymal cells[J]. Endocrine, 2018, 60(3): 423-434.
[19] Drucker DJ, Nauck MA.The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes[J]. Lancet, 2006, 368(9548): 1696-1705.
[20] He J, Wang C, Sun Y, et al.Exendin-4 protects bone marrow-derived mesenchymal stem cells against oxygen/glucose and serum deprivation-induced apoptosis through the activation of the cAMP/PKA signaling pathway and the attenuation of ER stress[J]. Int J Mol Med, 2016, 37(4): 889-900.
[21] Kim JY, Lee SK, Jo KJ, et al.Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes[J]. Life Sci, 2013, 92(10): 533-540.
[22] Guo Z, Chen R, Zhang F, et al.Exendin-4 relieves the inhibitory effects of high glucose on the proliferation and osteoblastic differentiation of periodontal ligament stem cells[J]. Arch Oral Biol, 2018, 91(1): 9-16.